Public attitude towards the HPV vaccine in the European Union 2020-2022

Published by Statista Research Department, May 6, 2024

In 2022, around three-quarters of EU citizens surveyed agreed the HPV vaccine was both important to have and safe. However, the share who thought this was higher in 2020. 

Share of the public who agreed with the following statements regarding the HPV vaccine in the European Union (EU) from 2020 to 2022

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

November 2022

Region

EU

Survey time period

2020 to 2022

Number of respondents

25,143 respondents

Supplementary notes

Data shows the share of respondents who agreed with the following statements:

HPV influenza vaccine is important

HPV vaccine is safe

HPV vaccine is effective

HPV vaccine is compatible with religious, personal, or philosophical beliefs.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Vaccination in France "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Vaccination in France

Global overview

6

The vaccine market: overview

4

The vaccine market: SANOFI

5

Vaccine coverage in France

8

Vaccine reluctancy

8

COVID-19: vaccine coverage

6

COVID-19: vaccine reluctancy

8

Further Content: You might find this interesting as well

Topics

Vaccination in FranceVaccinations in the U.S.Vaccinations in EuropeVaccine hesitancy in the U.S.Vaccinations in Canada
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu